Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
China Shineway Pharmaceutical Group Limited ( (HK:2877) ) has issued an update.
China Shineway Pharmaceutical Group Limited has announced its upcoming annual general meeting (AGM) scheduled for May 29, 2025, in Hong Kong. Key agenda items include the re-election of directors, re-appointment of auditors, and resolutions to authorize share repurchase and issuance. These actions are aimed at maintaining corporate governance and providing flexibility in capital management, potentially impacting shareholder value and market positioning.
More about China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited is a company in the pharmaceutical industry, primarily focused on the production and distribution of traditional Chinese medicine products. The company operates in the Hong Kong market and is incorporated in the Cayman Islands.
YTD Price Performance: -19.48%
Average Trading Volume: 1,260,537
Technical Sentiment Signal: Hold
Current Market Cap: HK$5.82B
Learn more about 2877 stock on TipRanks’ Stock Analysis page.